Xoma Licenses Technology To Pfizer

Pfizer Inc. (PFE) will pay Xoma Ltd. (XOMA) $30 million to license bacterial cell expression technology. Shares of Xoma climbed 40 cents to close at $2.68 while Pfizer stock eased 29 cents to close at $24.47.